Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease

Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel Disease

(2013) S. V. Rana et al.   DIGESTIVE DISEASES AND SCIENCES

Bioavailability profile of Uceris MMX extended-release tablets compared with Entocort EC capsules in healthy volunteers

(2013) Andrew Nicholls et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Drugs as causative agents and therapeutic agents in inflammatory bowel disease

(2013) Phani Krishna Kondamudi et al.   Acta Pharmaceutica Sinica B

Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration

(2012) Barbara M. Davit et al.   AAPS Journal

Role of metabolism by human intestinal microflora in geniposide-induced toxicity in HepG2 cells

(2012) Mi Jeong Kang et al.   ARCHIVES OF PHARMACAL RESEARCH

Degradation kinetics of metronidazole and olsalazine by bacteria in ascending colon and in feces of healthy adults

(2011) Maria Vertzoni et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Review article: Drug development in inflammatory bowel disease: budesonide-a model of targeted therapy

(2010) R. HAMEDANI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tuberculosis pulmonar en relación con adalimumab: estudio de 3 casos

(2009) José J. Blanco Pérez et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications

(2008) Barbara M. Davit et al.   AAPS Journal

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT

In situ fiber optic method for long-term in vitro release testing of microspheres

(2008) Jennifer M. Voisine et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Scintigraphic evaluation of colon targeting pectin–HPMC tablets in healthy volunteers

(2008) L.A. Hodges et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Use of the BioDis to generate a physiologically relevant IVIVC

(2008) S KLEIN et al.   JOURNAL OF CONTROLLED RELEASE

Interplay Between Intestinal pH, Transit Time and Feed Status on the In Vivo Performance of pH Responsive Ileo-Colonic Release Systems

(2008) Valentine C. Ibekwe et al.   PHARMACEUTICAL RESEARCH